Dual Somatic Mutations Trigger Tumor-Like Angiogenesis in Brain Cavernomas
For the roughly 0.5% of the population carrying cerebral cavernous malformations (CCMs), the threat of seizure or hemorrhagic stroke currently has no medical…
Found 2029 results for "cancer"
For the roughly 0.5% of the population carrying cerebral cavernous malformations (CCMs), the threat of seizure or hemorrhagic stroke currently has no medical…
Hormone receptor-positive breast cancer is the most common breast cancer subtype, and for decades its treatment rested on a relatively stable pharmacological…
For women carrying BRCA1 or BRCA2 mutations alongside a breast cancer diagnosis, the calculus of preventive surgery is consequential: prophylactic removal of…
Cervical cancer kills hundreds of thousands of women annually, yet the global elimination roadmap has largely been drawn along income lines — an approach this…
Biological age may matter more than calendar age in determining disease risk — and protein-based clocks could finally give clinicians a scalable way to…
Chronic pain affects a substantial proportion of cancer patients at every stage of disease, yet it remains undertreated partly because clinicians and…
For patients exhausting treatment options in advanced solid tumors, antibody-drug conjugates represent one of oncology's most active frontiers…
KRAS-mutant pancreatic cancer remains one of oncology's most formidable challenges, with fewer than 12% of patients surviving five years. Any strategy capable…
The VOYAGER consortium has assembled one of the largest head and neck cancer (HNC) genomic resources to date, pooling data from five North American and…
For the nearly one million Americans living with chronic lymphocytic leukemia or small lymphocytic lymphoma, standard oncology assessments may be missing a…
Anxiety in thyroid cancer is systematically overlooked by the clinicians who treat it — and that gap has real consequences for treatment decisions…
The assumption that cancer is a disease confined to rogue cells and their immediate tissue environment is being systematically dismantled. Emerging evidence…
For the roughly half-million men globally living under androgen deprivation therapy (ADT) for prostate cancer, the side-effect burden — fatigue, muscle loss…
The biggest survival gains in prostate cancer over the past decade have not come from refining care for early-stage disease — they've come from transforming…
The discovery that a well-known cell-cycle kinase doubles as a transcriptional gatekeeper — and that blocking it could make tumors more visible to the immune…
As artificial intelligence accelerates into clinical oncology, a critical question has been largely overlooked: do patients actually trust these tools, and…
For cancer patients enduring taxane chemotherapy, peripheral neuropathy — the numbness, tingling, and pain that can persist long after treatment — remains one…
One of oncology's most tantalizing puzzles — why localized radiation sometimes shrinks tumors far beyond the treatment field — is now closer to a working…
Breast cancer screening has long been governed by age thresholds that treat a 40-year-old with dense tissue and a family history identically to one without…
Bloodstream infections caused by Staphylococcus aureus carry a mortality burden that rivals many cancers, yet decades of clinical practice have rested on an…